Skip to main content
Center for U.S. Policy
search
Menu
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • search
Center for U.S. Policy
Close Search
Some Lawmakers Fear Buprenorphine Diversion After X-Waiver Eliminated

Some Lawmakers Fear Buprenorphine Diversion After X-Waiver Eliminated

News February 18, 2023
Biden Administration Announces 2023 Plans to Address Drug Poisoning Crisis

Biden Administration Announces 2023 Plans to Address Drug Poisoning Crisis

News February 9, 2023
Cost of Opioid Use Disorder

Cost of Opioid Use Disorder

News February 5, 2023
DEA To Propose Telehealth Regulations

DEA To Propose Telehealth Regulations

News February 2, 2023
CMS Approves California’s Section 1115 Waiver to Expand Medicaid to Incarcerated Individuals

CMS Approves California’s Section 1115 Waiver to Expand Medicaid to Incarcerated Individuals

News February 1, 2023
FDA Announces Need for New Regulatory Pathway for CBD

FDA Announces Need for New Regulatory Pathway for CBD

News January 30, 2023
DEA Announces Removal of Buprenorphine Waiver Requirements

DEA Announces Removal of Buprenorphine Waiver Requirements

News January 30, 2023
NIH Supports Broad Portfolio of Cannabis Research

NIH Supports Broad Portfolio of Cannabis Research

News January 25, 2023
HHS Proposes Permanent MOUD Regulatory Flexibilities

HHS Proposes Permanent MOUD Regulatory Flexibilities

News January 23, 2023
FBI Reveals Federal Agencies Probe into Private Lives of Americans

FBI Reveals Federal Agencies Probe into Private Lives of Americans

News January 23, 2023
Loading...
Print page

© 2026 Center for U.S. Policy. All Rights Reserved.

Close Menu
  • About
  • Issues
  • Initiatives
  • Events
  • Media